How do pharma companies report rebate accruals in earnings?

Manufacturers report net revenue after estimating rebate liabilities, which are accrued quarterly based on contracted rates and projected utilization. The rebate accrual estimate is one of the most judgment-intensive items on a pharma balance sheet. Accrual adjustments (favorable or unfavorable) can swing quarterly EPS by 5-15% and are closely watched by analysts.